Dataset Viewer
pharma_company
stringclasses 562
values | brand_name_en
stringlengths 19
232
| generic_name_en
stringlengths 21
250
| substance_name_en
stringclasses 983
values | atc_code_raw
stringclasses 778
values | anatomical_desc
stringclasses 14
values | therapeutic_desc
stringclasses 82
values | pharmacological_desc
stringclasses 181
values | subpharmacological_desc
stringclasses 365
values | chemical_desc
stringclasses 636
values |
---|---|---|---|---|---|---|---|---|---|
Aburaihan Pharmaceutical Co | TESTOSTERONE ENANTHATE INJECTION PARENTERAL 100 mg/1mL mL | TESTOSTERONE ENANTHATE INJECTION PARENTERAL 100 mg/1mL | TESTOSTERONE ENANTHATE | G03BA03 | GENITO URINARY SYSTEM AND SEX HORMONES | SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | ANDROGENS | 3-oxoandrosten (4) derivatives | testosterone |
Shafa Pharmaceutical & Hygienic Mfg.co. | SUMATRIPTAN TABLET ORAL 50 mg | SUMATRIPTAN (AS SUCCINATE) TABLET ORAL 50 mg | SUMATRIPTAN (AS SUCCINATE) | N02CC01 | NERVOUS SYSTEM | ANALGESICS | ANTIMIGRAINE PREPARATIONS | Selective serotonin (5HT1) agonists | sumatriptan |
Hakim Pharmaceutical Co. | VITAKIM-B TABLET ORAL 300 mg | VITAMIN B1 (THIAMINE) TABLET ORAL 300 mg | VITAMIN B1 (THIAMINE) | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Shahid Ghazi Pharmaceutical Co. | ACETAMINOPHEN INJECTION, SOLUTION INTRAVENOUS 10 mg/1mL 100 mL | ACETAMINOPHEN INJECTION, SOLUTION INTRAVENOUS 10 mg/1mL 100 mL | ACETAMINOPHEN | N02BE01 | NERVOUS SYSTEM | ANALGESICS | OTHER ANALGESICS AND ANTIPYRETICS | Anilides | paracetamol |
Iran Najo | CLO-GYN SUPPOSITORY VAGINAL 100 mg g | CLOTRIMAZOLE SUPPOSITORY VAGINAL 100 mg | CLOTRIMAZOLE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Exir Pharmaceutical Company | LACTULOSE SYRUP ORAL 10 g/15mL 240 mL | LACTULOSE SYRUP ORAL 10 g/15mL 240 mL | LACTULOSE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Avicenna Laboratories Inc. | THEOOHYLLINE CAPSULE, COATED, EXTENDED RELEASE ORAL 300 mg | THEOPHYLLINE CAPSULE, COATED, EXTENDED RELEASE ORAL 300 mg | THEOPHYLLINE | R03DA04 | RESPIRATORY SYSTEM | DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | Xanthines | theophylline |
Amin Pharmaceutical Co. | LEVOFECT TABLET ORAL 500 mg | LEVOFLOXACIN TABLET ORAL 500 mg | LEVOFLOXACIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Darou Pakhsh | CLINDAMYCIN INJECTION PARENTERAL 150 mg/1mL 2 mL | CLINDAMYCIN (AS PHOSPHATE) INJECTION PARENTERAL 150 mg/1mL 2 mL | CLINDAMYCIN (AS PHOSPHATE) | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Iran Daru | LIDOCAINE GEL TOPICAL 2 % 15 g | LIDOCAINE HYDROCHLORIDE GEL TOPICAL 2 % 15 g | LIDOCAINE HYDROCHLORIDE | D04AB01 | DERMATOLOGICALS | ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. | ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. | Anesthetics for topical use | lidocaine |
Ramopharmin | DOXEPIN CAPSULE ORAL 25 mg | DOXEPIN CAPSULE ORAL 25 mg | DOXEPIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Raha Pharmaceutical Isfahan Company | SULFACETAMIDE SOLUTION, DROPS OPHTHALMIC 10 % 10 mL | SULFACETAMIDE SODIUM SOLUTION, DROPS OPHTHALMIC 10 % 10 mL | SULFACETAMIDE SODIUM | S01AB04 | SENSORY ORGANS | OPHTHALMOLOGICALS | ANTIINFECTIVES | Sulfonamides | sulfacetamide |
Amin Pharmaceutical Co. | AMIPHEN SOLUTION, DROPS ORAL 100 mg/1mL 15 mL | ACETAMINOPHEN SOLUTION, DROPS ORAL 100 mg/1mL 15 mL | ACETAMINOPHEN | N02BE01 | NERVOUS SYSTEM | ANALGESICS | OTHER ANALGESICS AND ANTIPYRETICS | Anilides | paracetamol |
Sobhandarou | SOLIFEX TABLET ORAL 5 mg | SOLIFENACIN SUCCINATE TABLET ORAL 5 mg | SOLIFENACIN SUCCINATE | G04BD08 | GENITO URINARY SYSTEM AND SEX HORMONES | UROLOGICALS | UROLOGICALS | Drugs for urinary frequency and incontinence | solifenacin |
Caspian Tamin Co. | SODIUM BICARBONATE INJECTION PARENTERAL 8.4 % 10 mL | SODIUM BICARBONATE INJECTION PARENTERAL 8.4 % 10 mL | SODIUM BICARBONATE | B05XA02 | BLOOD AND BLOOD FORMING ORGANS | BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS | I.V. SOLUTION ADDITIVES | Electrolyte solutions | sodium bicarbonate |
Emad Darman Pars | LIDOCAINE H-EMAD OINTMENT RECTAL 5 %/0.5 % 15 g | LIDOCAINE / HYDROCORTISONE ACETATE OINTMENT RECTAL 5 %/0.5 % 15 g | LIDOCAINE / HYDROCORTISONE ACETATE | N01BB52 | NERVOUS SYSTEM | ANESTHETICS | ANESTHETICS, LOCAL | Amides | lidocaine, combinations |
Sobhan Oncology | BICALUMID TABLET ORAL 50 mg | BICALUTAMIDE TABLET ORAL 50 mg | BICALUTAMIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Aburaihan Pharmaceutical Co | OVOCEASE TABLET ORAL 750 ug | LEVONORGESTREL TABLET ORAL 750 ug | LEVONORGESTREL | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Exir Pharmaceutical Company | MEROPENEM-EXIR INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg mg | MEROPENEM INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg | MEROPENEM | J01DH02 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | OTHER BETA-LACTAM ANTIBACTERIALS | Carbapenems | meropenem |
Osvah Pharmaceutical Co. | ROXICAM INJECTION PARENTERAL 20 mg/1mL mL | PIROXICAM INJECTION PARENTERAL 20 mg/1mL | PIROXICAM | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Zahravi Pharmaceutical | D-GAS CAPSULE, LIQUID FILLED ORAL 125 mg | SIMETHICONE (DIMETHICONE ACTIVATED) CAPSULE, LIQUID FILLED ORAL 125 mg | SIMETHICONE (DIMETHICONE ACTIVATED) | A07D | ALIMENTARY TRACT AND METABOLISM | ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS | ANTIPROPULSIVES | null | null |
Raha Pharmaceutical Isfahan Company | FOLIC ACID TABLET ORAL 1 mg | FOLIC ACID TABLET ORAL 1 mg | FOLIC ACID | B03BB01 | BLOOD AND BLOOD FORMING ORGANS | ANTIANEMIC PREPARATIONS | VITAMIN B12 AND FOLIC ACID | Folic acid and derivatives | folic acid |
Bayer Corp | NIMOTOP INJECTION, SOLUTION INTRAVENOUS 0.2 mg/1mL 50 mg | NIMODIPINE INJECTION, SOLUTION INTRAVENOUS 0.2 mg/1mL 50 mL | NIMODIPINE | C08CA06 | CARDIOVASCULAR SYSTEM | CALCIUM CHANNEL BLOCKERS | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS | Dihydropyridine derivatives | nimodipine |
Desitin | ORLEPT TABLET, DELAYED RELEASE ORAL 200 mg | VALPROATE SODIUM TABLET, DELAYED RELEASE ORAL 200 mg | VALPROATE SODIUM | N03AG01 | NERVOUS SYSTEM | ANTIEPILEPTICS | ANTIEPILEPTICS | Fatty acid derivatives | valproic acid |
Caspian Tamin Co. | HISTADIC INJECTION PARENTERAL 10 mg/1mL mL | CHLORPHENIRAMINE MALEATE INJECTION PARENTERAL 10 mg/1mL | CHLORPHENIRAMINE MALEATE | R06AB04 | RESPIRATORY SYSTEM | ANTIHISTAMINES FOR SYSTEMIC USE | ANTIHISTAMINES FOR SYSTEMIC USE | Substituted alkylamines | chlorphenamine |
Kishmedipharm | MOBIPHARM TABLET ORAL 15 mg | MELOXICAM TABLET ORAL 15 mg | MELOXICAM | M01AC06 | MUSCULO-SKELETAL SYSTEM | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | Oxicams | meloxicam |
Fatak Chemie Pars Pharmaceutical Co. | FAMOTIDINE TABLET ORAL 20 mg | FAMOTIDINE TABLET ORAL 20 mg | FAMOTIDINE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Shahre Daru | PAIN OFF CAPSULE, EXTENDED RELEASE ORAL 100 mg | DICLOFENAC SODIUM CAPSULE, EXTENDED RELEASE ORAL 100 mg | DICLOFENAC SODIUM | M01AB05 | MUSCULO-SKELETAL SYSTEM | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | Acetic acid derivatives and related substances | diclofenac |
Darou Pakhsh | GENTAMICIN SOLUTION, DROPS OPHTHALMIC 3 mg/1mL 5 mL | GENTAMICIN SOLUTION, DROPS OPHTHALMIC 3 mg/1mL 5 mL | GENTAMICIN | S03AA06 | SENSORY ORGANS | OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS | ANTIINFECTIVES | Antiinfectives | gentamicin |
Aburaihan Pharmaceutical Co | TESTOSTERONE ENANTHATE INJECTION PARENTERAL 250 mg/1mL mL | TESTOSTERONE ENANTHATE INJECTION PARENTERAL 250 mg/1mL | TESTOSTERONE ENANTHATE | G03BA03 | GENITO URINARY SYSTEM AND SEX HORMONES | SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | ANDROGENS | 3-oxoandrosten (4) derivatives | testosterone |
Toliddaru Pharma. Co. | BISACODYL SUPPOSITORY RECTAL 10 mg | BISACODYL SUPPOSITORY RECTAL 10 mg | BISACODYL | A06AB02 | ALIMENTARY TRACT AND METABOLISM | DRUGS FOR CONSTIPATION | DRUGS FOR CONSTIPATION | Contact laxatives | bisacodyl |
Cipla | DAUNORUBICIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 20 mg mg | DAUNORUBICIN (AS HYDROCHLORIDE) INJECTION, POWDER, FOR SOLUTION PARENTERAL 20 mg | DAUNORUBICIN (AS HYDROCHLORIDE) | L01DB02 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AGENTS | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES | Anthracyclines and related substances | daunorubicin |
Caspian Tamin Co. | NITRAL INJECTION PARENTERAL 5 mg/1mL 2 mL | NITROGLYCERIN INJECTION PARENTERAL 5 mg/1mL 2 mL | NITROGLYCERIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Fanavarihaye Novin Darouie Atieh | CHLORPROMAZINE TABLET ORAL 100 mg | CHLORPROMAZINE HYDROCHLORIDE TABLET ORAL 100 mg | CHLORPROMAZINE HYDROCHLORIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Exir Pharmaceutical Company | DICLOREN INJECTION PARENTERAL 25 mg/1mL 3 mL | DICLOFENAC SODIUM INJECTION PARENTERAL 25 mg/1mL 3 mL | DICLOFENAC SODIUM | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Afachemi | AFAXIM POWDER, FOR SUSPENSION ORAL 100 mg/5 mL 100 mg | CEFIXIME POWDER, FOR SUSPENSION ORAL 100 mg/5 mL 100 mL | CEFIXIME | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Farabi Pharmaceutical | FARGESIC CAPSULE ORAL 325 mg/40 mg/200 mg | ACETAMINOPHEN / CAFFEINE / IBUPROFEN CAPSULE ORAL 325 mg/40 mg/200 mg | ACETAMINOPHEN / CAFFEINE / IBUPROFEN | N02BE71 | NERVOUS SYSTEM | ANALGESICS | OTHER ANALGESICS AND ANTIPYRETICS | Anilides | paracetamol, combinations with psycholeptics |
zist Arvand Pharmed | PAGLIMET TABLET, EXTENDED RELEASE ORAL 5 mg/1000 mg | EMPAGLIFLOZIN / METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE ORAL 5 mg/1000 mg | EMPAGLIFLOZIN / METFORMIN HYDROCHLORIDE | null | null | null | null | null | null |
Farabi Pharmaceutical | FARAMOX BD POWDER, FOR SUSPENSION ORAL 200 mg/5 mL 70 mL | AMOXICILLIN POWDER, FOR SUSPENSION ORAL 200 mg/5 mL 70 mL | AMOXICILLIN | J01CA04 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | BETA-LACTAM ANTIBACTERIALS, PENICILLINS | Penicillins with extended spectrum | amoxicillin |
Darou Pakhsh | SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.9 % 1000 mL | SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.9 % 1000 mL | SODIUM CHLORIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Jalinous Pharmaceutical Co. | OMEPRAZOLE-JALINOUS CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg | OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg | OMEPRAZOLE | A02BC01 | ALIMENTARY TRACT AND METABOLISM | DRUGS FOR ACID RELATED DISORDERS | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | Proton pump inhibitors | omeprazole |
Darou Pakhsh | PIRACETAM TABLET ORAL 800 mg | PIRACETAM TABLET ORAL 800 mg | PIRACETAM | N06BX03 | NERVOUS SYSTEM | PSYCHOANALEPTICS | PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS | Other psychostimulants and nootropics | piracetam |
Mina Pharmaceutical&cosmetics Laboratory | ACETAMINOPHEN SOLUTION ORAL 120 mg/5mL 60 mL | ACETAMINOPHEN SOLUTION ORAL 120 mg/5mL 60 mL | ACETAMINOPHEN | N02BE01 | NERVOUS SYSTEM | ANALGESICS | OTHER ANALGESICS AND ANTIPYRETICS | Anilides | paracetamol |
Iran Daru | TETRACYCLINE CAPSULE ORAL 250 mg | TETRACYCLINE HYDROCHLORIDE CAPSULE ORAL 250 mg | TETRACYCLINE HYDROCHLORIDE | J01AA07 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | TETRACYCLINES | Tetracyclines | tetracycline |
Shafa Pharmaceutical & Hygienic Mfg.co. | AZITHROMYCIN-SHAFA CAPSULE ORAL 250 mg | AZITHROMYCIN CAPSULE ORAL 250 mg | AZITHROMYCIN | J01FA10 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS | Macrolides | azithromycin |
Sobhandarou | IMIPRAMINE TABLET ORAL 10 mg | IMIPRAMINE HYDROCHLORIDE TABLET ORAL 10 mg | IMIPRAMINE HYDROCHLORIDE | N06AA02 | NERVOUS SYSTEM | PSYCHOANALEPTICS | ANTIDEPRESSANTS | Non-selective monoamine reuptake inhibitors | imipramine |
Darou Pakhsh | PERPHENAZINE TABLET ORAL 4 mg | PERPHENAZINE TABLET ORAL 4 mg | PERPHENAZINE | N05AB03 | NERVOUS SYSTEM | PSYCHOLEPTICS | ANTIPSYCHOTICS | Phenothiazines with piperazine structure | perphenazine |
Iran Daru | CLOBETASOL CREAM TOPICAL 0.05 % 15 g | CLOBETASOL PROPIONATE CREAM TOPICAL 0.05 % 15 g | CLOBETASOL PROPIONATE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Zahravi Pharmaceutical | FLUCONAZOLE CAPSULE ORAL 150 mg | FLUCONAZOLE CAPSULE ORAL 150 mg | FLUCONAZOLE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Pharmachemie | ZINC OXIDE OINTMENT TOPICAL 25 % 30 g | ZINC OXIDE OINTMENT TOPICAL 25 % 30 g | ZINC OXIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Alhavi | EMPADIANCE-M TABLET ORAL 5 mg/1000 mg | EMPAGLIFLOZIN / METFORMIN HYDROCHLORIDE TABLET ORAL 5 mg/1000 mg | EMPAGLIFLOZIN / METFORMIN HYDROCHLORIDE | A10BD | ALIMENTARY TRACT AND METABOLISM | DRUGS USED IN DIABETES | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | Combinations of oral blood glucose lowering drugs | null |
Daana Pharma | CEFTRIAXON EBERTH INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g mg | CEFTRIAXONE (AS SODIUM) INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g | CEFTRIAXONE (AS SODIUM) | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Actero middleeast | LIPAXOL INJECTION PARENTERAL 6 mg/1mL 5 mg | PACLITAXEL INJECTION PARENTERAL 6 mg/1mL 5 mL | PACLITAXEL | L01CD01 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AGENTS | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | Taxanes | paclitaxel |
Toliddaru Pharma. Co. | MEMANTINE TABLET ORAL 10 mg | MEMANTINE HYDROCHLORIDE TABLET ORAL 10 mg | MEMANTINE HYDROCHLORIDE | N06D | NERVOUS SYSTEM | PSYCHOANALEPTICS | ANTI-DEMENTIA DRUGS | null | null |
Toliddaru Pharma. Co. | AZITHROMYCIN CAPSULE ORAL 500 mg | AZITHROMYCIN CAPSULE ORAL 500 mg | AZITHROMYCIN | J01FA10 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS | Macrolides | azithromycin |
Pars Darou | DESIPRAMINE TABLET ORAL 25 mg | DESIPRAMINE HYDROCHLORIDE TABLET ORAL 25 mg | DESIPRAMINE HYDROCHLORIDE | N06AA01 | NERVOUS SYSTEM | PSYCHOANALEPTICS | ANTIDEPRESSANTS | Non-selective monoamine reuptake inhibitors | desipramine |
Samisaz | ACETAMINOPHEN TABLET ORAL 500 mg | ACETAMINOPHEN TABLET ORAL 500 mg | ACETAMINOPHEN | N02BE01 | NERVOUS SYSTEM | ANALGESICS | OTHER ANALGESICS AND ANTIPYRETICS | Anilides | paracetamol |
Alhavi | CYPROHEPTADIN-ALHAVI TABLET ORAL 4 mg | CYPROHEPTADINE HYDROCHLORIDE TABLET ORAL 4 mg | CYPROHEPTADINE HYDROCHLORIDE | R06AX02 | RESPIRATORY SYSTEM | ANTIHISTAMINES FOR SYSTEMIC USE | ANTIHISTAMINES FOR SYSTEMIC USE | Other antihistamines for systemic use | cyproheptadine |
Aburaihan Pharmaceutical Co | EMABET TABLET ORAL 10 mg | EMPAGLIFLOZIN TABLET ORAL 10 mg | EMPAGLIFLOZIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Iran Hormone | SUNVIT INJECTION PARENTERAL 300000 [iU]/1mL mL | VITAMIN D3 INJECTION PARENTERAL 300000 [iU]/1mL | VITAMIN D3 | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Chemidarou | TYLANOL TABLET ORAL 500 mg | ACETAMINOPHEN TABLET ORAL 500 mg | ACETAMINOPHEN | N02BE01 | NERVOUS SYSTEM | ANALGESICS | OTHER ANALGESICS AND ANTIPYRETICS | Anilides | paracetamol |
Boehringer Ingelheim | SPIRIVA CAPSULE RESPIRATORY 18 ug | TIOTROPIUM (AS BROMIDE) CAPSULE RESPIRATORY 18 ug | TIOTROPIUM (AS BROMIDE) | R03BB04 | RESPIRATORY SYSTEM | DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS | Anticholinergics | tiotropium bromide |
Sobhan Oncology | XOPLAT INJECTION, SOLUTION, CONCENTRATE PARENTERAL 5 mg/1mL 10 mL | OXALIPLATIN INJECTION, SOLUTION, CONCENTRATE PARENTERAL 5 mg/1mL 10 mL | OXALIPLATIN | L01XA03 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AGENTS | OTHER ANTINEOPLASTIC AGENTS | Platinum compounds | oxaliplatin |
Darou Pakhsh | PIROXICAM GEL TOPICAL 0.5 g/100g 60 g | PIROXICAM GEL TOPICAL 0.5 g/100g 60 g | PIROXICAM | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Tehran Chemie Pharmaceutical Co. | GLIBOTEX TABLET ORAL 5 mg | GLIBENCLAMIDE TABLET ORAL 5 mg | GLIBENCLAMIDE | A10BB01 | ALIMENTARY TRACT AND METABOLISM | DRUGS USED IN DIABETES | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | Sulfonylureas | glibenclamide |
Amin Pharmaceutical Co. | BIPERIDEN TABLET ORAL 2 mg | BIPERIDEN HYDROCHLORIDE TABLET ORAL 2 mg | BIPERIDEN HYDROCHLORIDE | N04AA02 | NERVOUS SYSTEM | ANTI-PARKINSON DRUGS | ANTICHOLINERGIC AGENTS | Tertiary amines | biperiden |
Zahravi Pharmaceutical | GENTAMICIN INJECTION PARENTERAL 40 mg/1mL 1 mL | GENTAMICIN INJECTION PARENTERAL 40 mg/1mL 1 mL | GENTAMICIN | J01GB03 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | AMINOGLYCOSIDE ANTIBACTERIALS | Other aminoglycosides | gentamicin |
Alborzdarou | METRONIDAZOLE SUSPENSION ORAL 125 mg/5mL 120 mL | METRONIDAZOLE SUSPENSION ORAL 125 mg/5mL 120 mL | METRONIDAZOLE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Osvah Pharmaceutical Co. | OSVERAL TABLET, FOR SUSPENSION ORAL 125 mg | DEFERASIROX TABLET, FOR SUSPENSION ORAL 125 mg | DEFERASIROX | V03AC03 | VARIOUS | ALL OTHER THERAPEUTIC PRODUCTS | ALL OTHER THERAPEUTIC PRODUCTS | Iron chelating agents | deferasirox |
Dorsa darou | METOPROLOL TARTRATE TABLET ORAL 50 mg | METOPROLOL TARTRATE TABLET ORAL 50 mg | METOPROLOL TARTRATE | C07AB02 | CARDIOVASCULAR SYSTEM | BETA BLOCKING AGENTS | BETA BLOCKING AGENTS | Beta blocking agents, selective | metoprolol |
Jalinous Pharmaceutical Co. | VALSARTAN TABLET ORAL 80 mg | VALSARTAN TABLET ORAL 80 mg | VALSARTAN | C09CA03 | CARDIOVASCULAR SYSTEM | AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM | ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN | Angiotensin II receptor blockers (ARBs), plain | valsartan |
Toliddaru Pharma. Co. | VITAMIN A+D OINTMENT TOPICAL 850 [iU]/85 [iU]/1g 30 g | VITAMIN A / VITAMIN D OINTMENT TOPICAL 850 [iU]/85 [iU]/1g 30 g | VITAMIN A / VITAMIN D | A11CB | ALIMENTARY TRACT AND METABOLISM | VITAMINS | VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO | Vitamin A and D in combination | null |
Amin Pharmaceutical Co. | DILTIAZEM TABLET ORAL 60 mg | DILTIAZEM HYDROCHLORIDE TABLET ORAL 60 mg | DILTIAZEM HYDROCHLORIDE | C08DB01 | CARDIOVASCULAR SYSTEM | CALCIUM CHANNEL BLOCKERS | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS | Benzothiazepine derivatives | diltiazem |
Raha Pharmaceutical Isfahan Company | DILTIAZEM TABLET ORAL 60 mg | DILTIAZEM HYDROCHLORIDE TABLET ORAL 60 mg | DILTIAZEM HYDROCHLORIDE | C08DB01 | CARDIOVASCULAR SYSTEM | CALCIUM CHANNEL BLOCKERS | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS | Benzothiazepine derivatives | diltiazem |
Alborzdarou | VITAMIN B1 TABLET ORAL 300 mg | VITAMIN B1 (THIAMINE) TABLET ORAL 300 mg | VITAMIN B1 (THIAMINE) | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Jalinous Pharmaceutical Co. | FEXOFENADINE TABLET ORAL 180 mg | FEXOFENADINE HYDROCHLORIDE TABLET ORAL 180 mg | FEXOFENADINE HYDROCHLORIDE | R06AX26 | RESPIRATORY SYSTEM | ANTIHISTAMINES FOR SYSTEMIC USE | ANTIHISTAMINES FOR SYSTEMIC USE | Other antihistamines for systemic use | fexofenadine |
Raha Pharmaceutical Isfahan Company | BISMANTIN TABLET ORAL 120 mg | BISMUTH SUBCITRATE EQU. TO BISMUTH OXIDE TABLET ORAL 120 mg | BISMUTH SUBCITRATE EQU. TO BISMUTH OXIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Shahre Daru | SIMVASTATIN TABLET ORAL 20 mg | SIMVASTATIN TABLET ORAL 20 mg | SIMVASTATIN | C10AA01 | CARDIOVASCULAR SYSTEM | LIPID MODIFYING AGENTS | LIPID MODIFYING AGENTS, PLAIN | HMG CoA reductase inhibitors | simvastatin |
Amin Pharmaceutical Co. | AMILOPRA SOLUTION ORAL 1 mg/5mL 60 mL | LOPERAMIDE HYDROCHLORIDE SOLUTION ORAL 1 mg/5mL 60 mL | LOPERAMIDE HYDROCHLORIDE | A07DA03 | ALIMENTARY TRACT AND METABOLISM | ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS | ANTIPROPULSIVES | Antipropulsives | loperamide |
AryoGen Pharmed | ARNOXA INJECTION, SOLUTION, CONCENTRATE PARENTERAL 300 mg/16.7mL mg | POSACONAZOLE INJECTION, SOLUTION, CONCENTRATE PARENTERAL 300 mg/16.7mL | POSACONAZOLE | J02AC04 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIMYCOTICS FOR SYSTEMIC USE | ANTIMYCOTICS FOR SYSTEMIC USE | Triazole derivatives | posaconazole |
Amin Pharmaceutical Co. | TRIHEXYPHENIDYL TABLET ORAL 2 mg | TRIHEXYPHENIDYL HYDROCHLORIDE TABLET ORAL 2 mg | TRIHEXYPHENIDYL HYDROCHLORIDE | N04AA01 | NERVOUS SYSTEM | ANTI-PARKINSON DRUGS | ANTICHOLINERGIC AGENTS | Tertiary amines | trihexyphenidyl |
Raha Pharmaceutical Isfahan Company | CLOTRIMAZOLE CREAM VAGINAL 2 % 50 g | CLOTRIMAZOLE CREAM VAGINAL 2 % 50 g | CLOTRIMAZOLE | G01AF02 | GENITO URINARY SYSTEM AND SEX HORMONES | GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS | ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS | Imidazole derivatives | clotrimazole |
Nano Fanavaran Darouei Alvand (nanoalvand) | MEROLIC TABLET, DELAYED RELEASE ORAL 360 mg | MYCOPHENOLIC ACID TABLET, DELAYED RELEASE ORAL 360 mg | MYCOPHENOLIC ACID | L04AA06 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | IMMUNOSUPPRESSANTS | IMMUNOSUPPRESSANTS | Selective immunosuppressants | mycophenolic acid |
Sobhandarou | CLIDINIUM-C TABLET ORAL 2.5 mg/5 mg | CLIDINIUM / CHLORDIAZEPOXIDE TABLET ORAL 2.5 mg/5 mg | CLIDINIUM / CHLORDIAZEPOXIDE | A03CA02 | ALIMENTARY TRACT AND METABOLISM | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS | Synthetic anticholinergic agents in combination with psycholeptics | clidinium and psycholeptics |
null | ADVIFEN® 400MG PEARL CAPSULE, LIQUID FILLED ORAL 400 mg | IBUPROFEN CAPSULE, LIQUID FILLED ORAL 400 mg | IBUPROFEN | M01AE01 | MUSCULO-SKELETAL SYSTEM | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | Propionic acid derivatives | ibuprofen |
Aburaihan Pharmaceutical Co | ACETAMINOPHEN SUPPOSITORY RECTAL 125 mg | ACETAMINOPHEN SUPPOSITORY RECTAL 125 mg | ACETAMINOPHEN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Jalinous Pharmaceutical Co. | CODAFEIN TABLET ORAL 300 mg/15 mg/15 mg | ACETAMINOPHEN / CAFFEINE / CODEINE PHOSPHATE TABLET ORAL 300 mg/15 mg/15 mg | ACETAMINOPHEN / CAFFEINE / CODEINE PHOSPHATE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Alborzdarou | TRIAMCINOLONE INJECTION PARENTERAL 40 mg/1mL 1 mL | TRIAMCINOLONE ACETONIDE INJECTION PARENTERAL 40 mg/1mL 1 mL | TRIAMCINOLONE ACETONIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
NO.115 , Jalal St ., Esteqlal Town ,Tehran | PERPHENAZINE TABLET ORAL 2 mg | PERPHENAZINE TABLET ORAL 2 mg | PERPHENAZINE | N05AB03 | NERVOUS SYSTEM | PSYCHOLEPTICS | ANTIPSYCHOTICS | Phenothiazines with piperazine structure | perphenazine |
Samisaz | PANTOSS TABLET, DELAYED RELEASE ORAL 20 mg | PANTOPRAZOLE TABLET, DELAYED RELEASE ORAL 20 mg | PANTOPRAZOLE | A02BC02 | ALIMENTARY TRACT AND METABOLISM | DRUGS FOR ACID RELATED DISORDERS | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | Proton pump inhibitors | pantoprazole |
Farabi Pharmaceutical | CLOXACILLIN CAPSULE ORAL 250 mg | CLOXACILLIN (AS SODIUM) CAPSULE ORAL 250 mg | CLOXACILLIN (AS SODIUM) | J01CF02 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | BETA-LACTAM ANTIBACTERIALS, PENICILLINS | Beta-lactamase resistant penicillins | cloxacillin |
Exir Pharmaceutical Company | LANSULIN N INJECTION PARENTERAL 100 [iU]/1mL 3 [iU] | INSULIN ISOPHANE INJECTION PARENTERAL 100 [iU]/1mL 3 mL | INSULIN ISOPHANE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Shafa Pharmaceutical & Hygienic Mfg.co. | SUMATRIPTAN TABLET ORAL 50 mg | SUMATRIPTAN (AS SUCCINATE) TABLET ORAL 50 mg | SUMATRIPTAN (AS SUCCINATE) | N02CC01 | NERVOUS SYSTEM | ANALGESICS | ANTIMIGRAINE PREPARATIONS | Selective serotonin (5HT1) agonists | sumatriptan |
Amin Pharmaceutical Co. | METOLOW-S TABLET, EXTENDED RELEASE ORAL 47.5 mg | METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE ORAL 47.5 mg | METOPROLOL SUCCINATE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Soha Pharmaceutical Co. | AZITHROMYCIN SOHA CAPSULE ORAL 250 mg | AZITHROMYCIN CAPSULE ORAL 250 mg | AZITHROMYCIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Exir Pharmaceutical Company | BIZOPEX TABLET ORAL 10 mg | BISOPROLOL FUMARATE TABLET ORAL 10 mg | BISOPROLOL FUMARATE | C07AB07 | CARDIOVASCULAR SYSTEM | BETA BLOCKING AGENTS | BETA BLOCKING AGENTS | Beta blocking agents, selective | bisoprolol |
Iran Daru | TRIAMCINOLONE CREAM TOPICAL 0.1 % 15 g | TRIAMCINOLONE ACETONIDE CREAM TOPICAL 0.1 % 15 g | TRIAMCINOLONE ACETONIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Darou Pakhsh | KETOROLAC INJECTION, SOLUTION PARENTERAL 30 mg/1mL mL | KETOROLAC TROMETAMOL INJECTION, SOLUTION PARENTERAL 30 mg/1mL | KETOROLAC TROMETAMOL | M01AB15 | MUSCULO-SKELETAL SYSTEM | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | Acetic acid derivatives and related substances | ketorolac |
Razak Labratories | PRAZOSIN TABLET ORAL 1 mg | PRAZOSIN TABLET ORAL 1 mg | PRAZOSIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Pursina Pharmaceutical Co. | DIPHENHYDRAMINE SOLUTION ORAL 12.5 mg/5mL 60 mL | DIPHENHYDRAMINE HYDROCHLORIDE SOLUTION ORAL 12.5 mg/5mL 60 mL | DIPHENHYDRAMINE HYDROCHLORIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 30